Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.0K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

890
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
890
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryogenic sample preparation: Comparative analysis of Ga<sup>+</sup> and Xe<sup>+</sup> FIB milling for TEM and APT examination of zirconium.

Ultramicroscopy·2025
Same author

Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation: The PEARL-AF Study.

JACC. Advances·2024
Same author

Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care Unit.

JACC. Advances·2024
Same author

Design of substituted tetrahydrofuran derivatives for HIV-1 protease inhibitors: synthesis, biological evaluation, and X-ray structural studies.

Organic & biomolecular chemistry·2024
Same author

Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF.

Journal of cardiac failure·2024
Same author

Mobile Application-Based Communication Facilitation Platform for Family Members of Critically Ill Patients: A Randomized Clinical Trial.

JAMA network open·2024
Same journal

Recent advances in 1,3,5-triazine-based PI3K inhibitors for cancer therapy: a comprehensive review.

Future medicinal chemistry·2026
Same journal

Indole-based carbohydrazides as potent anti-proliferative leads and tubulin polymerization inhibitors: design, synthesis, cytotoxic evaluation, <i>in silico</i> ADMET and docking studies.

Future medicinal chemistry·2026
Same journal

Recent advances in the development of small molecule STK33 inhibitors.

Future medicinal chemistry·2026
Same journal

Biological evaluation and molecular docking of previously reported pyrazolo-thiazole derivatives as dual α-amylase and α-glucosidase inhibitors.

Future medicinal chemistry·2026
Same journal

Coumarin derivatives as antidiabetic agents: a comprehensive review on mechanistic insights, structure-activity relationships, <i>in silico</i> studies, and challenges.

Future medicinal chemistry·2026
Same journal

Expanding the tetrazole space: medicinal chemistry, biological diversity and structure-activity relationships.

Future medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Feb 25, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K

Decoding HIV resistance: from genotype to therapy.

Irene T Weber1, Robert W Harrison2

  • 1Department of Biology, Georgia State University, PO Box 4010, Atlanta, GA 30302-4010, USA.

Future Medicinal Chemistry
|August 10, 2017
PubMed
Summary
This summary is machine-generated.

Genetic variation in human immunodeficiency virus (HIV) drives drug resistance, complicating AIDS pandemic management. Computational methods analyzing viral genotype can predict resistance and guide treatment strategies effectively.

Keywords:
HIV/AIDSantiretroviral therapydrug resistance mutationsgenotype interpretationintegrase strand transfer inhibitornon-nucleoside reverse transcriptase inhibitornucleoside reverse transcriptase inhibitorprotease inhibitorsupervised machine learning

More Related Videos

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Related Experiment Videos

Last Updated: Feb 25, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Area of Science:

  • Virology
  • Computational Biology
  • Genetics

Background:

  • Genetic variation in HIV presents a significant obstacle to effective AIDS pandemic prevention and treatment.
  • Viral drug resistance arises from mutations in target proteins, reducing drug affinity or altering protein dynamics, allowing replication under drug pressure.

Purpose of the Study:

  • To discuss computational approaches for predicting HIV drug resistance from genotype data.
  • To highlight the importance of monitoring viral genotypes for guiding therapy.
  • To explore methods for improving resistance prediction accuracy.

Main Methods:

  • Review of computational approaches for predicting HIV drug resistance.
  • Discussion of rule-based methods derived from known resistance mutations.
  • Exploration of statistical and machine learning techniques for improved classification.
  • Consideration of atomic protein structure data as an additional predictive feature.

Main Results:

  • Prevalence of drug-resistant HIV strains necessitates genotype monitoring.
  • Computational methods offer promising strategies for predicting resistance.
  • Machine learning and structural data can enhance prediction accuracy beyond traditional rule-based systems.

Conclusions:

  • Monitoring HIV genotype is crucial due to the prevalence of drug-resistant strains.
  • Computational tools, particularly those employing machine learning and structural information, can significantly improve the prediction of drug resistance.
  • These advancements aid in guiding personalized therapy for HIV patients.